Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016263
Filing Date
2025-05-13
Accepted
2025-05-13 08:00:57
Documents
57
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr20250331_10q.htm   iXBRL 10-Q 818850
2 EXHIBIT 10.1 ex_816252.htm EX-10.1 34824
3 EXHIBIT 31.1 ex_764710.htm EX-31.1 13260
4 EXHIBIT 31.2 ex_764711.htm EX-31.2 13215
5 EXHIBIT 32.1 ex_764712.htm EX-32.1 8388
11 mp01.jpg GRAPHIC 42677
  Complete submission text file 0001437749-25-016263.txt   4797115

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20250331.xsd EX-101.SCH 41466
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20250331_cal.xml EX-101.CAL 21027
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20250331_def.xml EX-101.DEF 302052
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20250331_lab.xml EX-101.LAB 272992
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20250331_pre.xml EX-101.PRE 321763
60 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20250331_10q_htm.xml XML 645018
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 25937226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)